United Capital Financial Advisers, LLC Zoetis Inc. Transaction History

United Capital Financial Advisers, LLC

$11.5 Billion
Q2 2024

A detailed history of United Capital Financial Advisers, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 20,279 shares of ZTS stock, worth $3.63 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

20,279

Previous 23,212 12.64%

Holding current value

$3.63 Million

Previous $3.93 Million 10.49%

% of portfolio

0.03%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$145.54 - $178.83 $426,868 - $524,508	-2,933 Reduced 12.64%	20,279 $3.52 Million
Q1 2024 May 15, 2024	SELL	$165.67 - $199.94 $683,554 - $824,952	-4,126 Reduced 15.09%	23,212 $3.93 Million
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $3.27 Million - $4.32 Million	-21,589 Reduced 44.12%	27,338 $5.4 Million
Q3 2023 Nov 14, 2023	SELL	$167.14 - $192.77 $109,142 - $125,878	-653 Reduced 1.32%	48,927 $8.51 Million
Q2 2023 Aug 14, 2023	SELL	$160.94 - $186.23 $413,132 - $478,052	-2,567 Reduced 4.92%	49,580 $8.54 Million
Q1 2023 Aug 14, 2023	BUY	$145.48 - $175.02 $373,447 - $449,276	2,567 Added 5.18%	52,147 $8.68 Million
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $461,171 - $554,813	-3,170 Reduced 5.73%	52,147 $8.68 Million
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $2.13 Million - $2.56 Million	-16,232 Reduced 22.69%	55,317 $8.11 Million
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $519,311 - $639,290	-3,502 Reduced 4.67%	71,549 $10.6 Million
Q2 2022 Aug 11, 2022	BUY	$155.97 - $200.09 $344,225 - $441,598	2,207 Added 3.03%	75,051 $12.9 Million
Q1 2022 May 16, 2022	BUY	$181.39 - $234.03 $612,735 - $790,553	3,378 Added 4.86%	72,844 $13.7 Million
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $50,940 - $64,968	263 Added 0.38%	69,466 $17 Million
Q3 2021 Nov 15, 2021	BUY	$189.29 - $209.69 $2.1 Million - $2.33 Million	11,112 Added 19.13%	69,203 $13.4 Million
Q2 2021 Aug 13, 2021	BUY	$155.9 - $187.99 $7.58 Million - $9.13 Million	48,593 Added 511.61%	58,091 $10.8 Million
Q1 2021 May 14, 2021	BUY	$144.0 - $169.39 $83,088 - $97,738	577 Added 6.47%	9,498 $1.5 Million
Q4 2020 Feb 17, 2021	BUY	$157.07 - $174.35 $107,435 - $119,255	684 Added 8.3%	8,921 $1.48 Million
Q3 2020 Nov 13, 2020	BUY	$137.1 - $165.37 $43,049 - $51,926	314 Added 3.96%	8,237 $1.36 Million
Q2 2020 Aug 13, 2020	BUY	$111.92 - $142.53 $28,203 - $35,917	252 Added 3.29%	7,923 $1.09 Million
Q1 2020 May 15, 2020	SELL	$92.66 - $144.94 $349,050 - $545,988	-3,767 Reduced 32.93%	7,671 $903,000
Q4 2019 Feb 14, 2020	BUY	$116.25 - $133.25 $384,090 - $440,258	3,304 Added 40.62%	11,438 $1.51 Million
Q3 2019 Feb 14, 2020	BUY	$112.57 - $128.43 $915,644 - $1.04 Million	8,134 New	8,134 $1.01 Million
Q3 2019 Nov 14, 2019	SELL	$112.57 - $128.43 $2.6 Million - $2.97 Million	-23,127 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$97.98 - $114.28 $823,129 - $960,066	8,401 Added 57.05%	23,127 $2.61 Million
Q1 2019 May 14, 2019	SELL	$81.56 - $100.67 $765,766 - $945,190	-9,389 Reduced 38.93%	14,726 $1.48 Million
Q4 2018 Feb 14, 2019	BUY	$79.28 - $95.27 $467,434 - $561,711	5,896 Added 32.36%	24,115 $2.04 Million
Q3 2018 Nov 14, 2018	SELL	$83.5 - $93.23 $29,893 - $33,376	-358 Reduced 1.93%	18,219 $1.67 Million
Q2 2018 Aug 14, 2018	BUY	$79.9 - $89.2 $9,987 - $11,150	125 Added 0.68%	18,577 $1.58 Million
Q1 2018 May 15, 2018	BUY	$71.51 - $84.69 $479,832 - $568,269	6,710 Added 57.15%	18,452 $1.54 Million
Q4 2017 Feb 13, 2018	BUY	$63.24 - $72.8 $55,398 - $63,772	876 Added 8.06%	11,742 $846,000
Q3 2017 Nov 14, 2017	SELL	$59.73 - $65.4 $10,154 - $11,118	-170 Reduced 1.54%	10,866 $693,000
Q2 2017 Aug 14, 2017	BUY	N/A	11,036	11,036 $688,000

Others Institutions Holding ZTS

# of Institutions

1,923

Shares Held

424M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Account

United Capital Financial Advisers, LLC Zoetis Inc. Transaction History